Physician profile
Michael P Kim
NPI 1265637276
$50,845.57
in general payments reported to CMS, 2019-2025
8 companies · $3,382 in 2025
The $3,382 reported for 2025 was more than what 87% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2021: $913 · 2022: $182 · 2023: $19K · 2024: $26K · 2025: $3,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Travel and Lodging: $2,998 · Food and Beverage: $1,782 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,298.75 |
| Travel and Lodging | $2,998.04 |
| Food and Beverage | $1,781.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,710.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation | $45,240.72 | 2023-2025 | |
| Olympus Corporation of The Americas | $2,580.20 | 2023-2024 | |
| Intuitive Surgical, INC. | $1,018.55 | 2019-2022 | |
| Stryker Corporation | $913.01 | 2021 | |
| Medtronic, INC. | $578.51 | 2022-2024 | Signia |
| Ethicon US, LLC | $346.55 | 2023-2024 | Dermabond Prineo, Echelon Endopath, Echelon; Endopath |
| Jazz Pharmaceuticals INC. | $128.01 | 2025 | |
| Abbott Laboratories | $40.02 | 2022-2023 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.